Tarsus PharmaceuticalsTARS
13F holders, Q2 2026 (June 30)256holders +3
35new positions
34sold out
6famous investors
$62.95avg. 13F price*
At the end of Q2 2026, 256 institutions reported holding Tarsus Pharmaceuticals Inc. (TARS) in their 13F filings, up 3 from Q1 2026. 35 opened new positions and 34 sold out. The largest holders were BlackRock, Inc. ($242.7M), Deep Track Capital, LP ($230.8M) and RTW Investments, LP ($211.3M). 6 famous investors held it, including Israel Englander (0.1% of Millennium Management's portfolio), David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Tarsus Pharmaceuticals Inc.
- CUSIP
- 87650L103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 35 | $102.1M |
| Exits | 34 | $95.5M |
All 13F filers, Q1 2026 → Q2 2026: 6,083,323 shares bought and 4,493,996 shares sold, net +1,589,327 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 256 holders
| BlackRock, Inc. | 0.00% | Add +8.5% | 3,856,137 | $242.7M |
| Deep Track Capital, LP | 3.40% | Add +1.9% | 3,666,768 | $230.8M |
| RTW Investments, LP | 1.80% | Add +0.3% | 3,357,059 | $211.3M |
| Jupiter Topco LLC | 0.07% | — | 2,808,796 | $176.8M |
| Paradigm Biocapital Advisors LP | 3.27% | Add +8.3% | 2,775,649 | $174.7M |
| Morgan Stanley | 0.01% | Reduce -6.0% | 1,827,082 | $115.0M |
| Vanguard Capital Management LLC | 0.00% | Add +1.9% | 1,793,064 | $112.9M |
| Jennison Associates LLC | 0.06% | Reduce -2.8% | 1,663,655 | $104.7M |
| Tang Capital Management LLC | 4.51% | Add +31.9% | 1,568,266 | $98.7M |
| Millennium Management | 0.06% | Add +152.8% | 1,427,124 | $89.8M |
| Bank of America Corp. | 0.00% | Reduce -0.1% | 1,193,182 | $75.1M |
| Geode Capital Management, LLC | 0.00% | Reduce -1.4% | 1,105,689 | $69.6M |
| State Street Corp. | 0.00% | Add +9.7% | 1,072,951 | $67.5M |
| Vestal Point Capital, LP | 1.54% | Add +425.0% | 1,050,000 | $66.1M |
| Assenagon Asset Management S.A. | 0.08% | Reduce -26.0% | 947,495 | $59.6M |
| Invesco Ltd. | 0.00% | Add +5.8% | 785,808 | $49.5M |
| Goldman Sachs Group Inc. | 0.00% | Add +68.9% | 742,693 | $46.7M |
| Frazier Life Sciences Management, L.P. | 1.00% | No change | 728,644 | $45.9M |
| D. E. Shaw & Co. | 0.03% | Reduce -10.2% | 710,559 | $44.7M |
| FMR LLC | 0.00% | Reduce -8.2% | 672,949 | $42.4M |
| Nomura Asset Management International Inc. | 0.06% | Add +21.5% | 607,272 | $38.2M |
| Clearbridge Investments, LLC | 0.03% | Add +0.7% | 549,387 | $34.6M |
| Toronto Dominion Bank | 0.05% | No change | 510,253 | $32.1M |
| Lord, Abbett & Co. LLC | 0.09% | Reduce -43.1% | 479,266 | $30.2M |
| Massachusetts Financial Services Co. | 0.01% | New | 427,008 | $26.9M |
| Northern Trust Corp. | 0.00% | Add +9.5% | 386,611 | $24.3M |
| Vanguard Portfolio Management LLC | 0.00% | Add +14.7% | 385,137 | $24.2M |
| Loomis Sayles & Co. L P | 0.03% | Reduce -6.7% | 380,684 | $24.0M |
| TimesSquare Capital Management, LLC | 0.34% | Reduce -4.9% | 369,377 | $23.2M |
| Wasatch Advisors LP | 0.15% | New | 368,568 | $23.2M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +2.3% | 335,834 | $21.1M |
| Tri Locum Partners LP | 2.54% | Add +30.0% | 328,340 | $20.7M |
| MPM Bioimpact LLC | 1.24% | Reduce -2.4% | 322,007 | $20.3M |
| Driehaus Capital Management LLC | 0.12% | Reduce -65.7% | 317,576 | $20.0M |
| Squarepoint Ops LLC | 0.04% | Add +22.7% | 295,824 | $18.6M |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +5.0% | 286,289 | $18.0M |
| Franklin Resources Inc. | 0.00% | Reduce -14.3% | 286,008 | $18.0M |
| Artisan Partners Limited Partnership | 0.03% | Reduce -7.3% | 284,899 | $17.9M |
| Rock Springs Capital Management LP | 0.85% | Add +23.1% | 277,087 | $17.4M |
| Ensign Peak Advisors, Inc | 0.03% | Reduce -19.3% | 268,696 | $16.9M |
| T. Rowe Price Associates Inc. | 0.00% | Reduce -5.1% | 260,784 | $16.4M |
| Citadel Advisors | 0.01% | Add +47.4% | 241,737 | $15.2M |
| BNP Paribas Financial Markets | 0.01% | Reduce -33.6% | 201,624 | $12.7M |
| Mackenzie Financial Corp. | 0.01% | New | 191,428 | $12.0M |
| Parkman Healthcare Partners LLC | 0.97% | New | 150,000 | $9.4M |
| JPMorgan Chase & Co. | 0.00% | Add +359.3% | 139,981 | $8.7M |
| Allspring Global Investments Holdings, LLC | 0.01% | Reduce -1.0% | 130,329 | $7.9M |
| Seven Fleet Capital Management LP | 1.31% | Add +491.3% | 117,067 | $7.9M |
| Caption Management, LLC | 0.28% | Add +231.2% | 120,700 | $7.6M |
| Jefferies Financial Group Inc. | 0.07% | No change | 118,810 | $7.5M |
| First Trust Advisors LP | 0.00% | Reduce -4.2% | 117,811 | $7.4M |
| Qube Research & Technologies Ltd | 0.01% | Reduce -64.1% | 116,363 | $7.3M |
| Bank of New York Mellon Corp | 0.00% | Add +7.2% | 114,458 | $7.2M |
| Wells Fargo & Company | 0.00% | Add +25.0% | 111,639 | $7.0M |
| Woodline Partners LP | 0.02% | No change | 100,443 | $6.3M |
| Cormorant Asset Management, LP | 0.32% | Reduce -55.6% | 100,000 | $6.3M |
| Schonfeld Strategic Advisors LLC | 0.03% | New | 99,845 | $6.3M |
| Canada Pension Plan Investment Board | 0.00% | Reduce -35.0% | 98,900 | $6.2M |
| Nuveen, LLC | 0.00% | Reduce -69.3% | 96,819 | $6.1M |
| XTX Topco Ltd | 0.08% | Add +84.2% | 95,130 | $6.0M |
| Connor, Clark & Lunn Investment Management Ltd. | 0.01% | Reduce -18.4% | 90,969 | $5.7M |
| Russell Investments Group, Ltd. | 0.01% | Reduce -38.6% | 89,526 | $5.6M |
| HighVista Strategies LLC | 1.25% | Add +65.9% | 87,060 | $5.5M |
| Sands Capital Alternatives, LLC | 0.87% | No change | 85,000 | $5.3M |
| Commonwealth Equity Services, LLC | 0.01% | Reduce -1.2% | 79,888 | $5.0M |
| UBS Group AG | 0.00% | Reduce -10.5% | 73,528 | $4.6M |
| Freestone Grove Partners LP | 0.03% | New | 68,389 | $4.3M |
| Mutual of America Capital Management LLC | 0.04% | Reduce -4.7% | 67,825 | $4.3M |
| Citigroup Inc. | 0.00% | Add +23.9% | 67,298 | $4.2M |
| Deutsche Bank AG | 0.00% | Reduce -46.3% | 65,457 | $4.1M |
| Federated Hermes, Inc. | 0.01% | Add +32.6% | 65,096 | $4.1M |
| Healthcare of Ontario Pension Plan Trust Fund | 0.01% | Reduce -43.4% | 61,600 | $3.9M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Reduce -1.9% | 61,514 | $3.9M |
| Emerald Investment Advisers, LLC | 0.25% | Add +49.8% | 59,747 | $3.8M |
| Swiss National Bank | 0.00% | Reduce -5.1% | 59,733 | $3.8M |
| State of Wisconsin Investment Board | 0.01% | Reduce -11.0% | 59,681 | $3.8M |
| Alliancebernstein L.P. | 0.00% | Add +25.6% | 51,029 | $3.6M |
| Eversept Partners, LP | 0.19% | New | 55,710 | $3.5M |
| Y-Intercept (Hong Kong) Ltd | 0.07% | Add +387.7% | 54,671 | $3.4M |
| Jacobs Levy Equity Management, Inc. | 0.01% | New | 53,636 | $3.4M |
| Rhumbline Advisers | 0.00% | Add +12.3% | 52,718 | $3.3M |
| EFG International AG | 0.05% | Add +36.4% | 46,552 | $2.9M |
| Cinctive Capital Management LP | 0.12% | Reduce -32.8% | 46,182 | $2.9M |
| E. Ohman J:or Asset Management AB | 0.07% | Add +8.8% | 45,794 | $2.9M |
| Trexquant Investment LP | 0.02% | Add +86.6% | 44,152 | $2.8M |
| Voleon Capital Management LP | 0.05% | Reduce -37.0% | 43,405 | $2.7M |
| Alps Advisors Inc. | 0.01% | Add +25.2% | 43,365 | $2.7M |
| AQR Capital Management | 0.00% | Add +37.9% | 42,003 | $2.6M |
| Odyssean, LLC | 0.42% | Add +201.3% | 41,394 | $2.6M |
| PFM Health Sciences, LP | 0.22% | Reduce -49.4% | 40,579 | $2.6M |
| Wellington Management Group LLP | 0.00% | Add +149.9% | 40,202 | $2.5M |
| Atika Capital Management LLC | 0.25% | New | 40,000 | $2.5M |
| Vontobel Holding Ltd. | 0.01% | Add +310.1% | 40,000 | $2.5M |
| New York State Common Retirement Fund | 0.00% | Add +9.4% | 39,303 | $2.5M |
| Baird Financial Group, Inc. | 0.00% | Reduce -7.3% | 38,898 | $2.4M |
| HSBC Holdings PLC | 0.00% | Add +295.0% | 38,090 | $2.4M |
| Manufacturers Life Insurance Company, The | 0.00% | Add +2.1% | 38,198 | $2.4M |
| Barclays PLC | 0.00% | Add +30.9% | 36,658 | $2.3M |
| California State Teachers Retirement System | 0.00% | Reduce -3.5% | 36,365 | $2.3M |
| Two Sigma Investments, LP | 0.00% | Add +88.9% | 36,038 | $2.3M |
"% of holder's portfolio" is TARS's weight in each manager's 13F, not the share of Tarsus Pharmaceuticals Inc. the manager owns.